ArticleCancer medicine2026

CRISPR Screen Reveals Pathways and Factors Driving Tyrosine Kinase Inhibitor Resistance in Hepatocellular Carcinoma.

Si-Yu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.